Filter Results:
(1,697)
Show Results For
- All HBS Web
(3,397)
- People (10)
- News (973)
- Research (1,697)
- Events (6)
- Multimedia (34)
- Faculty Publications (706)
Show Results For
- All HBS Web
(3,397)
- People (10)
- News (973)
- Research (1,697)
- Events (6)
- Multimedia (34)
- Faculty Publications (706)
Sort by
- 15 Feb 2000
- Research & Ideas
Growing Pains: Prescriptions for U.S. Health Care
at its upper end." Christensen sees the same pattern in health care. Sophisticated procedures and treatments, along with an abundance of highly trained professionals, have combined to drive costs out of... View Details
- September 2022
- Article
Cost of Cardiac Stereotactic Body Radioablation Therapy versus Catheter Ablation for Treatment of Ventricular Tachycardia
By: Chen Wei, Michelle Boeck, Pierre C. Qian, Todd Vivenzio, Zoe Elizee, Jeremy S. Bredfeldt, Robert S. Kaplan, Usha Tedrow, Raymond Mak and Paul C. Zei
Cardiac SBRT is a novel way of treating refractory ventricular tachycardia (VT) that may be less costly than catheter ablation, owing to its noninvasive, outpatient nature. We applied time-driven activity-based costing to both procedures. The direct and total... View Details
Wei, Chen, Michelle Boeck, Pierre C. Qian, Todd Vivenzio, Zoe Elizee, Jeremy S. Bredfeldt, Robert S. Kaplan, Usha Tedrow, Raymond Mak, and Paul C. Zei. "Cost of Cardiac Stereotactic Body Radioablation Therapy versus Catheter Ablation for Treatment of Ventricular Tachycardia." Pacing and Clinical Electrophysiology 45, no. 9 (September 2022): 1005–1179.
- Article
Defining the Value Framework for Prostate Brachytherapy Using Patient-Centered Outcome Metrics and Time-Driven Activity-Based Costing
By: N.G. Thaker, T.J. Pugh, U. Mahmood, S. Choi, T.E. Spinks, N.E. Martin, T.T. Sio, R.J. Kudchadker, R. S. Kaplan, D.A. Kuban, D.A. Swanson, P.F. Orio, M.J. Zelefsky, B.W. Cox, L. Potters, T.A. Buchholz, T.W. Feeley and S.J. Frank
PURPOSE:
Value, defined as outcomes over costs, has been proposed as a measure to evaluate prostate cancer (PCa) treatments. We analyzed standardized outcomes and time-driven activity-based costing (TDABC) for prostate brachytherapy (PBT) to define a value... View Details
Thaker, N.G., T.J. Pugh, U. Mahmood, S. Choi, T.E. Spinks, N.E. Martin, T.T. Sio, R.J. Kudchadker, R. S. Kaplan, D.A. Kuban, D.A. Swanson, P.F. Orio, M.J. Zelefsky, B.W. Cox, L. Potters, T.A. Buchholz, T.W. Feeley, and S.J. Frank. "Defining the Value Framework for Prostate Brachytherapy Using Patient-Centered Outcome Metrics and Time-Driven Activity-Based Costing." Brachytherapy 15, no. 3 (May 2016): 274–282.
- 2020
- Working Paper
Older People Are Less Pessimistic About the Health Risks of COVID-19
By: Pedro Bordalo, Katherine B. Coffman, Nicola Gennaioli and Andrei Shleifer
A central question for understanding behaviour during the COVID-19 pandemic, at both the individual and collective levels, is how people perceive the health and economic risks they face. We conducted a survey of over 1,500 Americans from May 6–13, 2020, to understand... View Details
Bordalo, Pedro, Katherine B. Coffman, Nicola Gennaioli, and Andrei Shleifer. "Older People Are Less Pessimistic About the Health Risks of COVID-19." NBER Working Paper Series, No. 27494, July 2020.
- 20 May 2016
- Op-Ed
World Health Organization Lacks Leadership to Combat Pandemics
When it comes to emergency preparedness for pandemics, the World Health Organization is falling short. It has not provided prompt and clear leadership to the world in combating either the Ebola or Zika viruses. Its leadership has been low... View Details
- 1977
- Chapter
Cost Benefit Analysis of Surgery: Some Additional Caveats and Interpretation
By: Jerry R. Green
Green, Jerry R. "Cost Benefit Analysis of Surgery: Some Additional Caveats and Interpretation." In Costs, Risks and Benefits of Surgery, edited by J. Bunker, B. Barnes, and F. Mosteller. New York: Oxford University Press, 1977.
- 14 Apr 2021
- Research & Ideas
The High Cost of the Slow COVID Vaccine Rollout
accounting that includes health care costs puts the savings figure closer to $1.3 trillion. And capacity to produce an additional 1 billion vaccine courses could similarly be worth on the order of $1... View Details
- March 2014
- Editorial
Limits on Use of Health Economic Assessments for Rare Diseases
By: Hanna I. Hyry, Ariel Dora Stern, Jonathan CP Roos and Timothy M. Cox
Funding of expensive treatments for rare ('orphan') diseases is contentious. These agents fare poorly on 'efficiency' or health economic measures, such as the QALY, because of high cost and frequently poor gains in quality of life and survival. We show that... View Details
Hyry, Hanna I., Ariel Dora Stern, Jonathan CP Roos, and Timothy M. Cox. "Limits on Use of Health Economic Assessments for Rare Diseases." hcu016. QJM: An International Journal of Medicine 107, no. 3 (March 2014): 241–245.
- 07 Mar 2000
- Research & Ideas
Putting Health Care Consumers in the Driver’s Seat
A mid-November conference on consumer-driven health care attracted nearly two hundred providers of health-care services, technology, and information; government professionals; and insurance executives to the HBS campus for a two-day... View Details
- 27 Feb 2020
- Sharpening Your Skills
How Following Best Business Practices Can Improve Health Care
care, but there is another cost to be accounted for. Germany May Have the Answer for Reducing Drug PricesIn Germany, drugmakers must prove that a new medication’s benefits merit a higher price than existing drugs. Making View Details
- 06 Apr 2015
- Research & Ideas
After Germanwings, More Attention Needed on Employee Mental Health
wrote the note, Mental Health and the American Workplace, exploring the extent of the phenomenon, its cost to organizations and employees, and some managerial responses. In some ways, it makes sense that... View Details
- June 2008 (Revised January 2010)
- Case
Name Your Price: Compensation Negotiation at Whole Health Management (A)
By: Brian J. Hall, Deepak Malhotra and Nicole Bennett
MBA student Monroe Davies is asked by a potential employer to determine his own compensation package. This case follows Jim Hummer, President and CEO of Whole Health Management and Davies through a unique recruitment process that raises questions of compensation and... View Details
Keywords: Compensation and Benefits; Recruitment; Job Interviews; Negotiation Process; Personal Development and Career; Motivation and Incentives; Value
Hall, Brian J., Deepak Malhotra, and Nicole Bennett. "Name Your Price: Compensation Negotiation at Whole Health Management (A)." Harvard Business School Case 908-064, June 2008. (Revised January 2010.)
- 08 Mar 2017
- Op-Ed
Op-Ed: Can the Proposed American Health Care Act Improve on 'Obamacare'?
their patient populations need, and workers and families can have the freedom and flexibility to make their own health care choices." This statement speaks to a strong attachment to personal freedom and... View Details
- 26 Jun 2000
- Research & Ideas
What’s an Internet Business Model? Ask a Health Care Professional
Though the Internet has woven itself into most aspects of life, few fields have adopted it more actively, and at times controversially, than health care. What new business models in health care, based on the... View Details
- 12 Jul 2020
- Research & Ideas
Solving COVID'S Mental Health Crisis
staying away or unable to pay and rising costs for personal protective gear and new technology. “Compounding the problem, SUD treatment and prevention programs risk draconian cuts to public funding as states... View Details
- November 2012 (Revised January 2013)
- Case
Companion Diagnostics: Uncertainties for Approval and Reimbursement
By: Richard G. Hamermesh, Norman C. Selby and Phillip Andrews
The FDA approvals of novel therapeutics were seen as signs in the personalized medicine community of real progress in the growth of personalized medicine. The FDA's approval of such drugs, along with companion diagnostics, suggested a shift in thinking and regulatory... View Details
Keywords: Models Of Reimbursement; Personalized Medicine; Regulation; Healthcare Reform; Health Care and Treatment; Health Industry; United States
Hamermesh, Richard G., Norman C. Selby, and Phillip Andrews. "Companion Diagnostics: Uncertainties for Approval and Reimbursement." Harvard Business School Case 813-037, November 2012. (Revised January 2013.)
- June 2014 (Revised February 2017)
- Case
Kathy Giusti and the Multiple Myeloma Research Foundation
By: Richard G. Hamermesh, Joshua D. Margolis and Matthew G. Preble
What do you do when your rising professional career is cut short by an unexpected cancer diagnosis? Kathy Giusti shifted careers, built a new organization that transformed how cancer research is done, and now faces the challenge of sustaining the organization and its... View Details
Keywords: Philanthropy; Philanthropy Funding; Entrepreneurship; Health Care; Management Styles; Personalized Medicine; Health Care Outcomes; Cancer; Cancer Care In The U.S.; Personal Care; Leadership; Leading Change; Social Entrepreneurship; Philanthropy and Charitable Giving; Health Care and Treatment; Leadership Style; Management Style; Management Skills; Growth and Development Strategy; Business Strategy; Health; Health Industry; United States; Canada; Spain
Hamermesh, Richard G., Joshua D. Margolis, and Matthew G. Preble. "Kathy Giusti and the Multiple Myeloma Research Foundation." Harvard Business School Case 814-026, June 2014. (Revised February 2017.)
- 05 Aug 2002
- Research & Ideas
Are Consumers the Cure for Broken Health Insurance?
The health insurance system in the United States is broken, and business is paying the price. Employers' insurance premiums reached an estimated $450 billion in 2000, and then shot up again, at three times the rate of inflation, in 2001.... View Details
Keywords: by Regina E. Herzlinger
- 27 Sep 2013
- Working Paper Summaries
The Impact of Conformance and Experiential Quality on Healthcare Cost and Clinical Performance
- January 2014
- Teaching Note
Dr. Benjamin Hooks and Children's Health Forum
By: Rosabeth Moss Kanter and Ai-Ling Malone
The case includes law, business, and public health perspectives on an African American leader's social entrepreneurship and leadership in other social movements. Later in his life, Dr. Benjamin Hooks championed the eradication of lead poisoning. Prior to that Hooks... View Details